Reuters: Regulatory News: UPDATE 1-U.S. FDA approves Vivus weight-management drug Qsymia

Reuters: Regulatory News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals. // via fulltextrssfeed.com

UPDATE 1-U.S. FDA approves Vivus weight-management drug Qsymia Jul 17th 2012, 23:41 Tue Jul 17, 2012 7:41pm EDT NEW YORK, July 17 (Reuters) - U.S. drugs regulators approved Vivus Inc's obesity drug on Tuesday, marking the second new diet pill approved in the last month. The U.S. Food and Drug Administration approved the pill, to be sold under the brand name Qsymia, after delaying the decision by three months to review the company's risk management plan. Although it came within weeks of the FDA's approval of Arena Pharmaceuticals' weight-buster Belviq last month, the approvals follow a 13-year dry spell for drugs for long-term weight loss.

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions